Balloni A, Assael B M, Ghio L, Pedrazzi C, Nebbia G, Gridelli B, Melada E, Panuccio A, Foti M, Barbi M, Luraschi C
Department of Pediatrics, University of Milano Medical School, Italy.
Vaccine. 1999 Jun 4;17(20-21):2507-11. doi: 10.1016/s0264-410x(99)00064-x.
Few studies have considered the safety, efficacy and appropriateness of vaccinations in pediatric patients before and after solid organ transplantation. The aim of this study was to evaluate the immune status after primary vaccination to diphtheria, tetanus and poliomyelitis in pediatric patients before and after hepatic transplantation and to poliomyelitis in pediatric patients before and after renal transplantation. All the patients had received a complete primary immunization schedule for diphtheria and tetanus and poliomyelitis. Immunity to the three polioviruses was evaluated in 56 patients with renal transplant, 27 on chronic dialysis and 33 controls and in 39 patients with hepatic transplant, 25 with chronic hepatic failure and their 36 controls. Immunity to diphtheria and tetanus was evaluated in 52 liver transplant patients, 29 children with chronic hepatic failure and 54 healthy children. Renal transplant patients were less protected and had lower antibody geometric mean titers than healthy controls for polioviruses 1 and 2. Whereas, protection in the children liver transplant patients was similar to that in their controls. Patients with chronic hepatic failure had higher antibody geometric mean titers to diphtheria and polioviruses 1 and 3 than their control group. Immunosuppression after transplantation has a negative influence on the immune status after primary vaccination in children with renal transplant. Whereas children with chronic hepatic failure have higher antibodies than a normal population. When possible, it could be advisable to individualize immunization schedules in patients at high risk.
很少有研究考虑过实体器官移植前后儿科患者接种疫苗的安全性、有效性和适宜性。本研究的目的是评估肝移植前后儿科患者白喉、破伤风和脊髓灰质炎初次接种疫苗后的免疫状态,以及肾移植前后儿科患者脊髓灰质炎初次接种疫苗后的免疫状态。所有患者均已完成白喉、破伤风和脊髓灰质炎的完整基础免疫程序。对56例肾移植患者、27例接受慢性透析的患者和33例对照,以及39例肝移植患者、25例慢性肝衰竭患者及其36例对照,评估了对三种脊髓灰质炎病毒的免疫力。对52例肝移植患者、29例慢性肝衰竭儿童和54例健康儿童评估了对白喉和破伤风的免疫力。肾移植患者对脊髓灰质炎病毒1型和2型的保护作用低于健康对照,抗体几何平均滴度也较低。而肝移植儿童患者的保护作用与对照组相似。慢性肝衰竭患者对白喉、脊髓灰质炎病毒1型和3型的抗体几何平均滴度高于其对照组。移植后的免疫抑制对肾移植儿童初次接种疫苗后的免疫状态有负面影响。而慢性肝衰竭儿童的抗体水平高于正常人群。如有可能,对高危患者的免疫接种计划进行个体化安排可能是明智的。